Integrated Filing — IndAS



General information about company

Scrip Code 530803
NSE Symbol BHAGERIA
MSEI Symbol NA
ISIN INE354C01027
Name of company BHAGERIA INDUSTRIES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Date of board meeting when results were approved 02-Aug-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 25-Jul-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 02-Aug-2025   10:00:00
End date and time of board meeting 02-Aug-2025   11:30:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 1574837000
Other income 64841000
Total income 1639678000
2 Expenses
(a) Cost of materials consumed 1064460000
(b) Purchases of stock-in-trade 72039000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -99419000
(d) Employee benefit expense 66345000
(e) Finance costs 9928000
(f) Depreciation, depletion and amortisation expense 77574000
(f) Other Expenses
1 Other Expenses 294526000 294526000
Total other expenses 294526000
Total expenses 1485453000
3 Total profit before exceptional items and tax 154225000
4 Exceptional items 0
5 Total profit before tax 154225000
6 Tax expense
7 Current tax 51236000
8 Deferred tax -5837000
9 Total tax expenses 45399000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0
11 Net Profit Loss for the period from continuing operations 108826000
12 Profit (loss) from discontinued operations before tax 0
13 Tax expense of discontinued operations 0
14 Net profit (loss) from discontinued operation after tax 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0
16 Total profit (loss) for period 108826000
17 Other comprehensive income net of taxes -34000
18 Total Comprehensive Income for the period 108792000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 112689000
Total profit or loss, attributable to non-controlling interests -3863000
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 112655000
Total comprehensive income for the period attributable to owners of parent non-controlling interests -3863000
21 Details of equity share capital
Paid-up equity share capital 218221000
Face value of equity share capital 5
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 2.58
Diluted earnings (loss) per share from continuing operations 2.58
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0
Diluted earnings (loss) per share from discontinued operations 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 2.58
Diluted earnings (loss) per share from continuing and discontinued operations 2.58
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes on financial results :-ttttt n1tThe Unaudited Consolidated Financial Result for the quarter ended June 30 2025 have been reviewed by the Audit Committee and thereafter approved by the Board of Directors at the meeting held on August 02, 2025. The Statutory Auditors of the Company have carried out Limited Review of the above results as per Regulatlon 33 of the SEBI Listing Obligation and Disclosure Requirements Regulations 2015.tttt n2tThe figures for the quarters ended on March 31 2025 are the balancing figures between audited figures for the full financial year and published year to date figures up to the third quarter of the respective financial year.tttt n3tCorresponding figures of previous year quarter have been re-grouped re-arranged where considered necessary, to correspond to current year quarter.tttt n4tIn accordance with Ind AS 108 Operating Segments, the Company has identified the following three reportable segments n(a) Chemicals, which include Organic Chemicals and Inorganic Chemicals (b) Solar Power encompassing the Generation and Distribution of Solar Power; and (c) Pharma and (d) Others, consisting of Trading and EPC in Solartttt n5tThe full financial results are also available on the stock exchanges' website i.e. www.bseindia.com and www.nseindia.com and on the Company's website i.e. www.bhageriagroup.com.tttt n



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2025
Date of end of reporting period 30-Jun-2025
Whether accounts are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Chemical 1467773000 1467773000
2 Solar Power 69838000 69838000
3 Pharma 12693000 12693000
4 Others 24533000 24533000
Total Segment Revenue 1574837000
Less: Inter segment revenue 0 0
Revenue from operations 1574837000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Chemical 150794000 150794000
2 Solar Power 27234000 27234000
3 Pharma -20282000 -20282000
4 Others -11860000 -11860000
Total Profit before tax 145886000
i. Finance cost 9928000 9928000
ii. Other Unallocable Expenditure net off Unallocable income -18267000 -18267000
Profit before tax 154225000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Chemical 4998737000 4998737000
2 Solar Power 1482797000 1482797000
3 Pharma 190170000 190170000
4 Others 197836000 197836000
Total Segment Asset 6869540000 6869540000
Un-allocable Assets 495040000 495040000
Net Segment Asset 7364580000 7364580000
4 Segment Liabilities
Segment Liabilities
1 Chemical 860330000 860330000
2 Solar Power 189624000 189624000
3 Pharma 140415000 140415000
4 Others 147604000 147604000
Total Segment Liabilities 1337973000 1337973000
Un-allocable Liabilities 355778000 355778000
Net Segment Liabilities 1693751000 1693751000
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of the defined benefit plans -370000 -370000
Total Amount of items that will not be reclassified to profit and loss -370000
2 Income tax relating to items that will not be reclassified to profit or loss -94000
3 Amount of items that will be reclassified to profit and loss
1 Exchange differences on translation of foreign operations 242000 242000
Total Amount of items that will be reclassified to profit and loss 242000
4 Income tax relating to items that will be reclassified to profit or loss 0
5 Total Other comprehensive income -34000





Details of Impact of Audit Qualification

Whether results are audited or unaudited Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Sarada & Pareek LLP Yes 31-Dec-2025